Clinical Trials Directory

Trials / Completed

CompletedNCT01880164

Cost Effectiveness of Nonoperative Management for Adult Spinal Deformity

Cost Effectiveness of Nonoperative Management for Adult Spinal Deformity Associated With Low Grade Scoliosis: A Prospective Pilot Study to Evaluate Disease Burden and Longitudinal Study Feasibility

Status
Completed
Phase
Study type
Observational
Enrollment
21 (actual)
Sponsor
Shay Bess · Academic / Other
Sex
All
Age
40 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Quantify the efficacy and cost of nonoperative treatment modalities used for adult spinal deformity.

Detailed description

1. Identify disease burden associated with adult spinal deformity (ASD) using quality adjusted life year (QALY) analysis. 2. Identify disease burden of specific demographic and radiographic features associated with ASD. 3. Compare disease burden of ASD to other musculoskeletal and non-musculoskeletal diseases. 4. Identify efficacy of specific nonoperative treatment modalities to treat ASD and identify specific clinical and radiographic features of ASD responsive to nonoperative treatment modalities. 5. Compare QALY and ICER values for different ASD nonoperative treatment modalities to previously established QALY and ICER for values for operative and nonoperative treatment modalities for degenerative hip and knee disease, coronary artery disease, insulin dependent diabetes, and hypertension. 6. Evaluate the cost and work hours associated with data collection and minimum 85% patient follow up. 7. Evaluate patient characteristics associated with poor patient compliance for study follow up including demographic, radiographic and HRQOL values and for reasons for cross-over to operative treatment for ASD. 8. Establish standardized data collection methodology for economic based outcome studies based upon patient demographics and HRQOL values.

Conditions

Timeline

Start date
2015-06-01
Primary completion
2017-01-01
Completion
2017-04-01
First posted
2013-06-18
Last updated
2017-04-06

Locations

10 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01880164. Inclusion in this directory is not an endorsement.